Log in
Enquire now
‌

US Patent 6849419 Monoclonal antibody hybridoma immunoassay method and diagnosis kit

Patent 6849419 was granted and assigned to WAKAMOTO PHARMACEUTICAL CO., LTD. on February, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
0
Current Assignee
WAKAMOTO PHARMACEUTICAL CO., LTD.
WAKAMOTO PHARMACEUTICAL CO., LTD.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
68494190
Patent Inventor Names
Masahiko Wakasugi0
Haruhisa Hirata0
Ritsuko Mochida0
Date of Patent
February 1, 2005
0
Patent Application Number
101116500
Date Filed
October 27, 2000
0
Patent Primary Examiner
‌
Lynette R. F. Smith
0
Patent abstract

The object of the present invention is to provide a diagnostic method by which Helicobacter pylori infection can be diagnosed at low cost without causing pain on subjects and without requiring particular equipment and which is free of cross reactivity and excellent in specificity without variation among lots as a result of the use of a single antibody facilitating the quality control and which shows good sensitivity even when a single monoclonal antibody is used.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 6849419 Monoclonal antibody hybridoma immunoassay method and diagnosis kit

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.